Table 3.
Results of the consensus meeting in comparison with Delphi survey scores
| Participants voting for exclusion (rated 1–3) (%) | Participants voting as no consensus (rated 4–6) (%) | Participants voting for inclusion (rated 7–9) (%) | ||||
|---|---|---|---|---|---|---|
| Outcome | Delphi | Consensus meeting | Delphi | Consensus meeting | Delphi | Consensus meeting |
| Voted as critical in the Delphi process | ||||||
| Mortality | 4 | 0 | 15 | 0 | 81 | 100 |
| Wound healing | 0 | 0 | 9 | 4 | 91 | 96 |
| Major amputation | 2 | 5 | 5 | 0 | 93 | 95 |
| Minor amputation | 2 | 4 | 13 | 4 | 85 | 91 |
| Ulcer recurrence | 0 | 0 | 11 | 17 | 89 | 83 |
| Time to healing | 1 | 0 | 14 | 17 | 85 | 83 |
| Infection | 1 | 8 | 9 | 8 | 90 | 83 |
| New ulceration | 1 | 5 | 10 | 18 | 89 | 77 |
| Health-related quality of life | 1 | 4 | 28 | 24 | 71 | 72 |
| Osteomyelitis | 0 | 8 | 11 | 21 | 89 | 71 |
| Hospital admission | 2 | 0 | 19 | 35 | 79 | 65 |
| Revascularization | 1 | 12 | 10 | 28 | 89 | 60 |
| Global quality of life | 1 | 12 | 16 | 32 | 83 | 56 |
| Cardiovascular events | 3 | 12 | 22 | 35 | 75 | 54 |
| Ambulatory status | 2 | 17 | 22 | 35 | 76 | 48 |
| Pain | 2 | 15 | 25 | 42 | 73 | 42 |
| Change in ulcer dimensions | 1 | 8 | 20 | 54 | 79 | 38 |
| Acute kidney injury | 8 | 15 | 20 | 50 | 72 | 35 |
| Need for antimicrobial treatment | 3 | 38 | 15 | 33 | 82 | 29 |
| Need for additional surgical procedures | 2 | 28 | 14 | 44 | 84 | 28 |
| Degree of granulation tissue | 5 | 25 | 25 | 54 | 70 | 21 |
| Tolerability | 1 | 24 | 13 | 56 | 86 | 20 |
| No consensus following the Delphi process | ||||||
| Length of hospital stay | 3 | 19 | 30 | 58 | 67 | 23 |
| Falls | 10 | 32 | 53 | 52 | 37 | 16 |
| Cerebrovascular events | 5 | 32 | 35 | 56 | 60 | 12 |
| Requirement for social care | 4 | 50 | 28 | 42 | 68 | 8 |
| Foot fracture | 2 | 56 | 29 | 40 | 69 | 4 |
| Levels of exudate | 6 | 68 | 32 | 28 | 62 | 4 |
| Psychological impact on partner | 6 | 68 | 38 | 28 | 56 | 4 |
| Sleep disturbance | 9 | 65 | 43 | 31 | 48 | 4 |
| Foot swelling | 8 | 76 | 28 | 24 | 64 | 0 |
| Odor | 13 | 81 | 42 | 19 | 45 | 0 |
| Wound bleeding | 8 | 81 | 48 | 19 | 44 | 0 |
| Anemia | 12 | 88 | 57 | 12 | 31 | 0 |
| Respiratory complications | 13 | 88 | 58 | 12 | 30 | 0 |
| Weight loss | 16 | 96 | 64 | 4 | 20 | 0 |
| Development of cataract | 41 | 96 | 51 | 4 | 8 | 0 |
Values are presented as a proportion of respondents selecting a specific rating for each outcome given in percentages. Outcomes for potential inclusion in COS are defined as ≥70% of respondents scoring as 7–9 (critical) and 1–3 by ≤15%. Outcomes for exclusion are defined as ≥70% of respondents scoring as 1–3 (not important) and 7–9 by ≤15%. Outcomes with consensus are defined as not meeting criteria for inclusion or exclusion.